The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) | Strategic Alliance Partners

Latest from The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS)


UAMS Breast Cancer Program Earns National Reaccreditation

September 21, 2022

The Breast Cancer program at the University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute has earned reaccreditation from the National Accreditation Program for Breast Centers.

Optimized Treatment Starts With Molecular Testing in NSCLC

January 14, 2022

Konstantinos Arnaoutakis, MD, discusses new strategies in the management of ALK-positive non–small cell lung cancer, frontline immunotherapy, targeting EGFR, and biomarkers and targeted therapies in early-stage and advanced disease.

UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients

August 17, 2021

Little Rock—The Myeloma Center at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences is offering a new cutting-edge immunotherapy treatment for myeloma patients.

Multidisciplinary Effort Key to Successful Lung Cancer Screening Programs

July 24, 2019

Mollie Meek, MD, highlights key lung cancer screening trials, offered insight into how to successfully implement an effective program, and stressed that collaboration is critical in order to provide the best patient care.